ABVC BioPharma
ABVC
ABVC
8 hedge funds and large institutions have $129K invested in ABVC BioPharma in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$42K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$31.5K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$31.6K |
| 4 |
4
Wells Fargo
San Francisco,
California
|
$23 |
Top Sellers
| 1 |
VF
1
Virtu Financial
New York
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$670 |
| 3 |
3
JPMorgan Chase & Co
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $42K | 36,100 | +36,100 | New |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $31.6K | 27,247 | +8,926 | +49% |
|
|
3
Citadel Advisors
Miami,
Florida
| $31.5K | 27,158 | +11,567 | +74% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $22.6K | 19,480 | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $670 | 578 | -2,407 | -81% |
|
|
SAG
6
Spotlight Asset Group
Oakbrook Terrace,
Illinois
| $104 | 100 | – | – |
|
|
7
Wells Fargo
San Francisco,
California
| $23 | 20 | +2 | +11% |
|
|
VF
8
Virtu Financial
New York
| – | – | -20,265 | Closed |
|
|
9
JPMorgan Chase & Co
New York
| – | – | -2 | Closed |
|
|
CFGS
10
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 37 | – | – |
|